3′-deoxy-3′-[F-18]fluorothymidine positron emission tomography in patients with recurrent glioblastoma multiforme: Comparison with Gd-DTPA enhanced magnetic resonance imaging

Molecular Imaging and Biology

Volumn 8, Issue 6, 2006, Pages 340-347

  Yamamoto, Yuka ^a,b   Wong, Terence Z ^a   Turkington, Timothy G ^a   Hawk, Thomas C ^a   Reardon, David A ^a   Coleman, R Edward ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b KAGAWA UNIVERSITY   (Japan)

Author keywords

F 18 FLT; Glioblastoma multiforme; PET

Indexed keywords

3' FLUOROTHYMIDINE F 18; ANTINEOPLASTIC AGENT; GADOLINIUM PENTETATE MEGLUMINE; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; FLUORINE; GADOLINIUM PENTETATE; THYMIDINE;

ADULT; AGED; ARTICLE; BRAIN SURGERY; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; INTERMETHOD COMPARISON; MALE; MEDICAL RECORD REVIEW; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECURRENT CANCER; BRAIN TUMOR; CHEMISTRY; EVALUATION; METHODOLOGY; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; SCINTISCANNING; TUMOR VOLUME;

ADULT; BRAIN NEOPLASMS; FEMALE; FLUORINE RADIOISOTOPES; GADOLINIUM DTPA; GLIOBLASTOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; THYMIDINE; TUMOR BURDEN;

EID: 33750969342     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-006-0063-2     Document Type: Article

References (37)

1. Rohren EM, Turkington TG, Coleman RE (2004) Clinical applications of PET in oncology. Radiology 231:305-332
2. Delbeke D, Meyerowitz C, Lapidus RL, et al. (1995) Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET. Radiology 195:47-52
3. Kaschten B, Stevenaert A, Sadzot B, et al. (1998) Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/ or carbon-11-methionine. J Nucl Med 39:778-785
4. Wong TZ, van der Westhuizen GJ, Coleman RE (2002) Positron emission tomography imaging of brain tumors. Neuroimaging Clin N Am 12:615-626
5. Weber W, Bartenstein P, Gross MW, et al. (1997) Fluorine-18-FDG-PET and iodine-123-IMT SPECT in the evaluation of brain tumors. J Nucl Med 38:802-808
6. Oriuchi N, Tomiyoshi K, Inoue T, et al. (1996) Independent thallium-201 accumulation and fluorine-18-fluorodeoxyglucose metabolism in glioma. J Nucl Med 37:457-462
7. Ricci PE, Karis JP, Heiserman JE, et al. (1998) Differentiating recurrent tumor from radiation necrosis: Time for re-evaluation of positron emission tomography? AJNR 19:407-413
8. 11C-methionine PET in the evaluation of brain lesions that are hypo- or isometabolic on 18 F-FDG-PET. Eur J Nucl Med Mol Imaging 29:176-182
9. Shields AF, Grierson JR, Dohmen BM, et al. (1998) Imaging proliferation in vivo with [F-18]FLT and positron emission tomography. Nat Med 4:1334-1336
10. Eary JF, Mankoff DA, Spence AM, et al. (1999) 2-[C-11]thymidine imaging of malignant brain tumors. Cancer Res 59:615-621
11. 18F α-methyl tyrosine PET studies in patients with brain tumors. J Nucl Med 40:399-405
12. 11C-methionine for diagnosis of recurrent brain tumor and radiation injury. Acta Radiol 32:197-202
13. Shields AF, Grierson JR, Kozawa SM, Zheng M (1996) Development of labeled thymidine analogs for imaging tumor proliferation. Nucl Med Biol 23:17-22
14. 18F]FLT for imaging of cellular proliferation in vivo. Nucl Med Biol 27:143-156
15. 18F]FLT: Portrait of a proliferation marker. Eur J Nucl Med Mol Imaging 29:165-169
16. Rasey JS, Grierson JR, Wiens LW, et al. (2002) Validation of FLT uptake as a measure of thymidine kinase-1 activity in A549 carcinoma cells. J Nucl Med 43:1210-1217
17. 18F-FDG. J Nucl Med 44:1426-1431
18. 18F]FLT uptake by positron emission tomography with Ki-67 immunohistochemistry and flow cytometry in human lung tumors. Clin Cancer Res 8:3315-3332
19. 18F]fluoro-2-deoxy-d-glucose in positron emission tomography for colorectal cancer. Eur J Nucl Med Mol Imaging 30:988-994
20. Francis DL, Freeman A, Visvikis D, et al. (2003) In vivo imaging of cellular proliferation in colorectal cancer using positron emission tomography. Gut 52:1602-1606
21. 18F-Fluoro-3′-deoxy-l-thymidine: A new tracer for staging metastatic melanoma? J Nucl Med 44:1927-1932
22. 18F-FDG-PET. J Nucl Med 45:226-231
23. 18F-3′-fluoro-3′-deoxy-l-thymidine. Clin Cancer Res 10:1685-1690
24. 18FLT utilisation in colorectal cancer. Eur J Nucl Med Mol Imaging 31:169-178
25. 18F]fluorothymidine for imaging of primary breast cancer: A pilot study. Eur J Nucl Med Mol Imaging 31:720-724
26. 18F-FDG-PET in esophageal cancer. J Nucl Med 46:400-404
27. 18F-FDG. J Nucl Med 46:945-952
28. 18F]3′-Deoxy- 3′-fluorothymidine PET for the diagnosis and grading of brain tumors. Eur J Nucl Med Mol Imaging 32:653-659
29. Kleihues P, Louis DN, Scheithauer BW, et al. (2002) The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61:215-225
30. DeGrado TR, Turkington TG, Williams JJ, Stearns CW, Hoffman JM, Coleman RE (1994) Performance characteristics of a whole-body PET scanner. J Nucl Med 35:1398-1406
31. 18F]fluorothymidine using (5′-O-dimethoxytrityl-2′-deoxy-3′-O- nosyl-β-d-threo pentofuranosyl)thymine and its 3-N-BOC-protected analogue as a labeling precursor. Nucl Med Biol 30:151-157
32. 18F]FLT. Nucl Med Biol 29:263-273
33. Pelizzari CA, Chen GTY, Spelbring DR, Weichselbaum RR, Chen CT (1989) Accurate three-dimensional registration of CT, PET and/or MR images of the brain. J Comput Assist Tomogr 13:20-26
34. Turkington TG, Hoffman JM, Jaszczak RJ, et al. (1995) Accuracy of surface fit registration for PET and MR brain images using full and incomplete brain surfaces. J Comput Assist Tomogr 19:117-124
35. Earnest F, Kelly PJ, Scheithauer BW, et al. (1988) Cerebral astrocytomas: Histopathologic correlation of MR and CT contrast enhancement with stereotactic biopsy. Radiology 166:823-827
36. Sherley JL, Kelly TJ (1988) Regulation of human thymidine kinase during the cell cycle. J Biol Chem 263:8350-8358
37. 11C methylmethionine as markers of increased transport and proliferation in brain tumors. J Nucl Med 46:1948-1958